Paul Lamers

Manufactures and supplies medical, dental, and hospital equipment

AlpInvest Partners invests in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing in form of debt and equity for buyout, secondary and growth stage capital requirements and also makes co investments.

Produces and supplies methylamines, related derivatives & amines

Functions as a College/University

TCH utilizes a value creation approach. Their investment strategy focuses on mid-sized firms with an enterprise value of EUR 25 million to EUR 350 million. They target firms headquartered in The Netherlands, Germany and Belgium operating in domestic, European or worldwide markets. Typical EBITA is a minimum of EUR 5 million. They seek to add value through international expansion, optimizing business through acquisitions and divestitures, enhancing operations, financial and tax structuring improvements, strengthening of management teams and managing succession issues. Investment criteria characteristics include niche market leaders with a competitive market position, positive and sustainable cash flows, and stable performances and significant growth potential. They are sector independent. They avoid investments in biotech/high-tech firms, distressed situations, or industries that are capital intensive, cyclical or encumbered with substantial regulatory risks. TCH seeks clear exit potential within four to seven years although the investment period is not fixed. Exit decisions are taken in partnership with the management and their shared vision for the firm.

Acts as an alternative investment manager

Gilde Equity Management invests in mid-sized and large companies located in Benelux, primarily in Netherlands, Belgium, and Luxembourg with an enterprise value of EUR 20 - 200 million. The firm focuses on companies across a broad range of sectors. It participates in debt and equity financing for acquisition & management buyout transactions with a transaction size of EUR 20 - 200 million. The firm acquires minority and majority interests.

Smile Invest invests in companies located in Western Europe. The firm targets companies operating in the fields of Software & Tech Industries, Healthcare and Consumer Products & Services with an investment size ranging from €10 to €50 million and revenues of €10 to €150 million. It provides financing in the form of equity and debt for management buyouts and growth capital requirements. The firm acquires minority or majority stake in the company.